{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:33Z","timestamp":1789609113490,"version":"build-2803163510"},"reference-count":51,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1080\/14712598.2024.2416947","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T12:49:56Z","timestamp":1729514996000},"page":"1261-1269","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":24,"title":["A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer\u2019s disease"],"prefix":"10.1080","volume":"24","author":[{"given":"Akanksha","family":"Chhabra","sequence":"first","affiliation":[{"name":"Department of Clinical Research, Jamia Hamdard School of Chemical and Life Sciences, Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Solanki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hindu Rao Hospital, Delhi, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvi","family":"Saravanabawan","sequence":"additional","affiliation":[{"name":"American MD Program, Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9258-9560","authenticated-orcid":false,"given":"Arun","family":"Venkiteswaran","sequence":"additional","affiliation":[{"name":"American MD Program, Faculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NagaTarang","family":"Nimmathota","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Central Florida College of Health Professions and Sciences, Orlando, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishi Manojkumar","family":"Modi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Government Medical College Surat, Surat, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"e_1_3_6_3_1","unstructured":"Dementia [Internet]. [cited 2024 Aug 3]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13016"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.16500"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00465-0"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00285-023-01985-7"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-51"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0664-z"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02196-w"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.08.010"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13470"},{"key":"e_1_3_6_14_1","unstructured":"What are the signs of Alzheimer\u2019s disease? National institute on aging [internet]. [cited 2024 Aug 3]. Available from: https:\/\/www.nia.nih.gov\/health\/alzheimers-symptoms-and-diagnosis\/what-are-signs-alzheimers-disease"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00976-6"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01858-9"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160"},{"key":"e_1_3_6_18_1","unstructured":"RoB 2: a revised Cochrane risk-of-bias tool for randomized trials | Cochrane bias [Internet]. [cited 2024 Aug 3]. Available from: https:\/\/methods.cochrane.org\/bias\/resources\/rob-2-revised-cochrane-risk-bias-tool-randomized-trials"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-016-0189-7"},{"issue":"2","key":"e_1_3_6_20_1","first-page":"197","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein S","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis [Internet]. 2022 Apr 1 [cited 2024 Aug 3];9(2):197\u2013210. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35542991\/","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"e_1_3_6_21_1","first-page":"142","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van D CH","year":"2023","unstructured":"van D CH, S CJ, A P, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med [Internet]. 2023 [cited 2024 Aug 3];388(1):142\u2013143. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36449413\/","journal-title":"N Engl J Med"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705971"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.06.1893"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312889"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0559-z"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0424-5"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-022-01124-2"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.09.224"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.10.001"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00813-8"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/03946320231209839"},{"issue":"6","key":"e_1_3_6_32_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jama.2023.12548","article-title":"Alzheimer drug lecanemab gains traditional FDA approval","volume":"330","author":"Harris E","year":"2023","unstructured":"Harris E. Alzheimer drug lecanemab gains traditional FDA approval. JAMA [Internet]. 2023 Aug 8 [cited 2024 Sep 18];330(6):495\u2013495. Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2807654","journal-title":"JAMA"},{"key":"e_1_3_6_33_1","unstructured":"Leqembi | European Medicines Agency (EMA) [Internet]. [cited 2024 Sep 18]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/leqembi"},{"key":"e_1_3_6_34_1","unstructured":"Project information | Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer\u2019s disease [ID4043] | Guidance | NICE [Internet]. [cited 2024 Sep 18]. Available from: https:\/\/www.nice.org.uk\/guidance\/indevelopment\/gid-ta11220"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature19323"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.4161"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2022.06.012"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2023.100467"},{"key":"e_1_3_6_39_1","unstructured":"Project information | aducanumab for treating mild cognitive impairment and mild dementia caused by Alzheimer\u2019s disease [ID3763] | guidance | NICE [Internet]. [cited 2024 Sep 18]. Available from: https:\/\/www.nice.org.uk\/guidance\/discontinued\/gid-ta10739"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n3127"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304839"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e3181c53b00"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.1538"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0559-z"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-110977"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304430"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4742-11.2012"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n156"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01858-9"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01938-w"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01534"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"e_1_3_6_53_1","unstructured":"FDA approves treatment for adults with Alzheimer\u2019s disease | FDA [Internet]. [cited 2024 Sep 18]. Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-adults-alzheimers-disease"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2024.2416947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T01:45:56Z","timestamp":1732844756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2024.2416947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1080\/14712598.2024.2416947"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2024.2416947","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}